Real-World Weight-Loss Effectiveness of GLP-1 Agonists Among Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Obesity
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Real-world weight-loss effectiveness of glucagon-like peptide-1 agonists among patients with type 2 diabetes: A retrospective cohort study
Obesity 2023 Feb 01;31(2)537-544, GE White, I Shu, D Rometo, J Arnold, M Korytkowski, J LuoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.